Aytu BioScience Inc. (AYTU)

[Drugdoctor]

So the S3 and S4 SEC filings authorize the sale of $140 million dollars worth of stock. At $1.40 per share that would be 100 million new shares. Since the authorized shares are 200 million shares, and there are 120 million shares already outstanding, will the company need to raise the authorized shares? Also, if the warrants are exercised, that may increase the need for more shares also?

I found this statement in the S3 filing..
https://www.sec.gov/Archives/edgar/data/1385818/000121390020014383/ea122646-s4_aytubioscience.htm

9

___________________________________________________________________

DESCRIPTION OF COMMON STOCK



General



This prospectus describes the general terms of our capital stock. For a more detailed description of our capital stock, you should read the applicable provisions of the Delaware General Corporation Law, or DGCL, and our charter and bylaws.



Our certificate of incorporation provides that we may issue up to 200,000,000 shares of common stock, par value $0.0001 per share, and up to 50,000,000 shares of preferred stock, par value $0.0001 per share, and permits our board of directors, without stockholder approval, to amend the charter to increase or decrease the aggregate number of shares of stock or the number of shares of stock of any class or series that we have authority to issue. As of June 1, 2020, there were 120,614,876 shares of our common stock outstanding and no shares of our preferred stock outstanding. Under Delaware law, stockholders generally are not personally liable for our debts or obligations solely as a result of their status as stockholders.